MICROINJECTION OF THE KAPPA OPIOID RECEPTOR AGONIST U‐50448H INTO THE MEDIAL PREOPTIC AREA INCREASES RENAL SNA AND DECREASES SODIUM EXCRETION WITHOUT SIGNIFICANTLY IMPACTING CARDIOVASCULAR FUNCTION